all AI news
Accelerating drug discovery with AI: Insights from Isomorphic Labs
April 25, 2024, 4 p.m. | Lukas Biewald
Gradient Dissent: Exploring Machine Learning, AI, Deep Learning, Computer Vision wandb.com
In this episode of Gradient Dissent, Isomorphic Labs Chief AI Officer Max Jaderberg, and Chief Technology Officer Sergei Yakneen join our host Lukas Biewald to discuss the advancements in biotech and drug discovery being unlocked with machine learning.
With backgrounds in advanced AI research at DeepMind, Max and Sergei offer their unique insights into the challenges and successes of applying AI in a complex field like biotechnology. They share their journey at Isomorphic Labs, a company dedicated to revolutionizing drug …
More from wandb.com / Gradient Dissent: Exploring Machine Learning, AI, Deep Learning, Computer Vision
Navigating the Vector Database Landscape with Pinecone's Edo Liberty
1 month, 1 week ago |
wandb.com
Transforming Data into Business Solutions with Salesforce AI CEO, Clara Shih
1 month, 3 weeks ago |
wandb.com
Transforming Data into Business Solutions with Salesforce AI CEO, Clara Shih
1 month, 3 weeks ago |
wandb.com
Shaping the World of Robotics with Chelsea Finn
2 months, 3 weeks ago |
wandb.com
Shaping the World of Robotics with Chelsea Finn
2 months, 3 weeks ago |
wandb.com
Jobs in AI, ML, Big Data
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US
Research Engineer
@ Allora Labs | Remote
Ecosystem Manager
@ Allora Labs | Remote
Founding AI Engineer, Agents
@ Occam AI | New York
AI Engineer Intern, Agents
@ Occam AI | US